Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 99 | 99 | 99 |
PDF Downloads | 79 | 79 | 79 |
In Mali, access to health care facilities (HCFs) is limited due to distance and transportation costs, and this limitation may have led to an under detection of COVID-19 cases. This prospective randomized study compared a community-based, integrated COVID-19 and malaria testing strategy (intervention arm) to the national standard-of-care strategy (SOC arm). Four health areas were randomly assigned. All people seeking care who accepted the study were enrolled by community health workers (CHWs) and screened for COVID-19 symptoms. In the intervention arm, CHWs performed COVID-19 and/or malaria antigen rapid diagnostic tests (Ag-RDTs) for patients who met clinical criteria for possible COVID-19, including fever. In the SOC arm, CHWs referred patients who met clinical criteria for possible COVID-19, including fever, to the nearest health care facility (HCF) in where COVID-19 and/or malaria Ag-RDTs were performed. Febrile patients refusing referral were tested for malaria by CHWs. Among 1,164 patients enrolled, 73% had fever and 72% meet clinical criteria for possible COVID-19. Malaria Ag-RDTs were performed in 79% and 3% COVID-19 suspected patients in intervention and SOC arms, respectively (P <0.001). Only three patients tested positive for COVID-19. Among 449 patients referred to HCFs, 248 refused to go tho the HCFs, and only 10 of 201 who agreed to the referral actually reached one. Among febrile patients, 75% and 34% received malaria treatment in intervention and SOC arms, respectively (P <0.001). Integration of community-based testing for COVID-19 and malaria Ag-RDTs was found to be feasible. However, limited access to HCFs in rural areas highlights the need for treatment services to be available at the community level.
Financial support: The study was supported through FIND, through a grant FIND received from the German Federal Ministry for Economic Cooperation and Development (BMZ).
Current contact information: Guillaume Breton, SOLTHIS and Department of Infectious Diseases, Pitié-Salpêtrière Hospital, Paris, France. E-mail: guillaume.breton@solthis.org; Issouf Maïga, Solthis, Niamey, Niger. E-mail: cdp.atdsdeid.niger@solthis.org; Aboubacar Maïga, Solthis, Bamako, Mali. E-mail: aboubacarmaiga5555@gmail.com; Gabrièle Laborde-Balen, TransVIHMI, Montpellier University, INSERM, IRD, Montpellier, France. E-mail : gabriele.laborde-balen@ird.fr; Luis Sagaon-Teyssier, Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, ISSPAM, Marseille, France. E-mail: luis.sagaon-teyssier@ird.fr; Anne Hoppe, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland. E-mail: ahoppe@pedaids.org; Odé Kanku Kabemba, Solthis, Conakry, Guinea. E-mail: dirpaysguinee@solthis.org; Boubacar Cissé, Solthis, Bamako, Mali. E-mail: dirpays.mali@solthis.org; Fatou Diawara Traore, National Institut of Public Health (INSP), Bamako, Mali. E-mail: diawarafatou@gmail.com.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 99 | 99 | 99 |
PDF Downloads | 79 | 79 | 79 |